Results 51 to 60 of about 8,037 (89)

Comparative study between calcium gluconate with diosmin, cabergoline, and cabergoline with diosmin in prevention of ovarian hyperstimulation syndrome in high-risk women undergoing intracytoplasmic sperm injection (ICSI) procedures. [PDF]

Front Pharmacol
Abdallah AM, Hussien AK, Alarfaj SJ, Elmasry TA, Kamal M, Sarhan H, Mosbeh MH, Sadek EM.   +7 more
europepmc   +1 more source

Comparative study of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndrome (OHSS) in PCOS patients: a pilot randomized clinical trial. [PDF]

J Ovarian Res
Salari E, Ajabi Ardehjani N, Kashani L, Jafari K, Moini A.   +4 more
europepmc   +1 more source

Correlation Between Fertility Stress, Psychological Capital, and Conjugal Communication Patterns in Hospitalized Patients with Ovarian Hyperstimulation Syndrome During in vitro Fertilization-Embryo Transfer Cycles. [PDF]

Int J Womens Health
Wu W, Zhou N, He Y.
europepmc   +1 more source

Ovarian Hyperstimulation Syndrome (OHSS): A Narrative Review and Legal Implications. [PDF]

J Pers Med
Gullo G, Cucinella G, Stojanovic V, Stojkovic M, Bruno C, Streva AV, Lopez A, Perino A, Marinelli S.   +8 more
europepmc   +1 more source

Analysis of couple communication patterns as a mediator of fertility-related stress and psychological capital in women with severe ovarian hyperstimulation syndrome after embryo transfer. [PDF]

Sci Rep
Lan M, Zhou N, Chen B, Yu H.
europepmc   +1 more source

Nomogram model to predict the risk of moderate to severe ovarian hyperstimulation syndrome of long protocol group in fresh cycle. [PDF]

Sci Rep
Deng H, Dou Q, Guo P, Liu H, Xiang Y, Geng X, Li P, Zhang D.   +7 more
europepmc   +1 more source

The Therapeutic Potential of EGCG and Pro-EGCG in Mitigating Ovarian Hyperstimulation Syndrome: Unraveling the Modulatory Mechanism through the VEGF Pathway. [PDF]

Int J Biol Sci
Wang S, Fang L, Cong L, Jia Q, Wu W, Zhao M, Li T, Chung JPW, Fung KK, Lam VCM, Sun Y, Cheng JC, Chan DYL.   +12 more
europepmc   +1 more source

Severe ovarian hyperstimulation syndrome in an oocyte donor despite preventive strategies. [PDF]

Clin Exp Reprod Med
Forgiarini A, Contreras MSP, Bontá S, Maggi S, Espinel LAQ.   +4 more
europepmc   +1 more source

Impact of gonadotropin selection on risk of ovarian hyperstimulation syndrome in predicted high responders: a Menopur in Gonadotropin-releasing hormone Antagonist Single Embryo Transfer-High Responder trial analysis. [PDF]

F S Rep
Foulk R, Slater CC, Karande V, Kelly LK, Foster ED, Heiser PW, Daftary GS, Lalwani S, Menopur in GnRH Antagonist Cycles with Single Embryo Transfer – High Responder (MEGASET-HR) Trial Group.   +8 more
europepmc   +1 more source

Ovarian Hyperstimulation syndrome combined with hypothyroidism: a comprehensive review. [PDF]

J Ovarian Res
Zhou J, Chen Y, Bai L, Zhou W, Yang H, Chen Y, Chen L, Lu R, Hu L, Wang S.   +9 more
europepmc   +1 more source